YOU ARE HERE: LAT HomeCollectionsHpv


November 9, 2010 | By Shari Roan, Los Angeles Times
The HPV vaccine was approved in 2006 as the first vaccine that can prevent a type of cancer. The vaccine protects against several common strains of human papilloma virus, which causes genital warts and can lead to cervical cancer. However, a new study show that a majority of young women who are eligible for the vaccine are either not getting it or are not following the three-shot protocol to be fully immunized. Researchers from the University of Maryland analyzed data from 9,658 teenagers and young women who were eligible for the HPV vaccination at the University of Maryland Medical Center between August 2006 and August 2010.
October 1, 2012 | By Jon Bardin
A large study of the safety of the HPV vaccine has turned up no unexpected side effects. The study, published Monday in the journal Archives of Pediatrics & Adolescent Medicine, did find that the vaccine caused some women to faint the day they received it, and some recipients also developed skin infections. Both problems are believed to be general side effects of vaccines, and unrelated to anything specific about the HPV shot. HPV, or human papillomavirus, is the most common sexually transmitted disease among American women.
December 20, 2011 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
Vaccination against human papilloma virus was recommended for U.S. girls almost five years ago. In October, a government advisory committee also recommended routine vaccination for boys ages 11 and 12.   But vaccinating girls only makes the most sense, researchers said Tuesday. Using mathematical models, researchers in the Netherlands found vaccinating girls is the best way to reduce heterosexual transmission because girls have the highest prevalence of the virus. Immunizing the group with the highest prevalence achieves the largest population-wide reduction of the virus.
September 8, 2011 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
The HPV vaccine, approved in 2006, requires three shots over a six-month period -- a regimen that is inconvenient and costly. But a new study shows a two-dose vaccine may work as well. The vaccine prevents infection from certain strains of the human papilloma virus, which can cause cervical cancer. It is considered revolutionary because it's the first vaccine to prevent a type of cancer. (It was even a topic of Wednesday night's Republican presidential candidates' debate because of Texas Gov. Rick Perry's proposal to mandate the vaccine in his state.)
October 25, 2011 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
The vaccine that protects against a sexually transmitted, human papilloma virus, should be routinely recommended to boys ages 11 and 12, a government advisory committee said Tuesday. The HPV vaccine is already advised for routine use in girls ages 11 to 12 to prevent cervical cancer. But a panel of health experts said that new data on the Gardasil vaccine's ability to curb the risk of anal cancer, particular among gay men, warrants adding boys to the list of people who should get the three-dose vaccine.
September 12, 2011 | By James Oliphant
Sensing vulnerability, Michele Bachmann and Rick Santorum went after Rick Perry - hard - on his order, while governor of Texas, to force young girls to be vaccinated against the human papillomavirus. In doing so, they sparked the sharpest exchange of the debate so far. During the CNN/Tea Party Express debate in Tampa, Bachmann also accused Perry of favoring a large pharamceutical company, Merck, in pushing the program. Perry said he made a mistake is issuing an executive order forcing the vaccinations, but he said he erred on the side of trying to prevent a deadly cancer.
September 16, 2011 | By Seema Mehta
Michele Bachmann, struggling to regain her footing in the GOP presidential contest, Friday assailed rival Rick Perry, saying he abused his power as governor of Texas and rewarded political donors in a manner similar to President Obama. "It's wrong to abuse executive authority with unilateral action, and of course the governor of Texas admitted as much that he made a mistake," Bachmann said, speaking to reporters after holding a rally in Costa Mesa. "People don't want a president or a governor making decisions based on political connections.
November 1, 2011
A government panel now recommends that the vaccine against human papillomavirus should be routinely given to boys as well as girls. Our question is: What took so long? Gardasil, the vaccine developed by Merck, protects against the HPV strains most likely to cause cervical cancer. Because its purpose is to reduce this scourge, it always made sense to treat it as a public health issue and vaccinate those who might spread the virus along with those who might actually get sick.
November 17, 2009 | Times Wire Reports
Immigrant girls and women will no longer have to be vaccinated against a sexually transmitted virus to get their green cards. Girls and women seeking to become legal permanent U.S. residents were required to get at least the first dose of the vaccine against human papillomavirus. Starting Dec. 14, the HPV vaccine will no longer be on the list of immunizations that immigrants must receive before getting their green card, the federal Centers for Disease Control and Prevention said Friday.
June 22, 2006 | Bonnie Miller Rubin and Judy Peres, Chicago Tribune
In a groundbreaking study that could influence the sex education debate, researchers have found that consistent and proper use of condoms significantly reduces the risk of contracting a virus that can cause cervical cancer. University of Washington researchers report today that female college students whose partners always wore condoms were 70% less likely to become infected with human papilloma virus, or HPV, than students whose partners used condoms less than 5% of the time.
Los Angeles Times Articles